Though most people with glaucoma manage well with an eye drop or two and retain their functional vision, a subgroup of glaucoma patients worsen catastrophically over time. Is it possible to identify which group your glaucoma patients will be in? And when should the comprehen…

Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.

What are your patients reading on their smart phone and how accurate is it? Drs. Drew Carey and Lorraine Provencher team up to answer this question from Dr. Natasha Nayak Kolomeyer as they discuss her Ophthalmology Glaucoma article, “What Glaucoma Patients Are Reading on the…

Drs. Lorraine Provencher and Matthew Emanuel give a crash course on minimally invasive glaucoma surgery (MIGS).

Michael S. Berlin, MD, director of the Glaucoma Institute of Beverly Hills, discusses excimer laser trabeculostomy (ELT) for treatment of outflow obstructions in open-angle glaucoma patients.

Dr. Steven Vold, a clinical investigator in the trials for the iStent Trabecular Micro-Bypass , shares his impressions on the place for microinvasive glaucoma surgery (MIGS), focusing on patient selection, contraindications, and the learning curve for introducing the iStent…

Leading experts discuss clinical experiences and the differences in caring for older adults.